A replay of the webcast of the R&D investor event is available on the “Events” page in the “Investor Relations & Media” section of the Company’s website at ...

4 Though the trials have not concluded, the clinical trial sponsors have already published their trial design methods, along with some promising interim results. 5 Models for success in Alzheimer ...

These findings overall have raised expectations for the phase 3 POETYK SLE trials that are underway. These trials (POETYK SLE 1 and POETYK SLE 2) are now recruiting patients and have the potential ...

Under this agreement, NetraMark's AI technology will initially be used for Phase 2 (neuroscience and oncology clinical trials) and select Phase 3 clinical trials conducted by Worldwide ...

Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

Global CRO Worldwide Clinical Trials has enlisted AI tech firm NetraMark to discover patient subpopulations hidden inside complex data sets. Under the partnership, Worldwide will use NetraMark’s ...

"However, in order to move toward our goal of launching clinical trials for these patients, an understanding of the natural history of these disorders is critical for developing outcome measures ...

Patients with moderate to severe active systemic lupus erythematosus (SLE) who began treatment with anifrolumab in the TULIP-1 and TULIP-2 trials experienced a statistically significant reduction ...

The meeting with the FDA regarding the design of our program may lead to the start of a trial in 2026. Early intervention may be particularly beneficial in pediatric patients, given the ...

Preliminary data in six patients from the Phase 1 dose confirmation clinical trial (CARLYSLE) in refractory systemic lupus erythematosus ... on the Phase 2 trial design and potential ...